VM
SIOX

VHCP Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

VHCP Management’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.29M Hold
23,014
– – 2.46% 10
2016
Q3 		$2.58M Hold
23,014
– – 2.54% 9
2016
Q2 		$2.36M Hold
23,014
– – 2.45% 10
2016
Q1 		$2.11M Buy
+23,014
New +$2.45M 1.84% 11

Other funds holding SIOX

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
IA
IPL Advisers New York $158M AUM 18.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VHCP Management's SIOX Position: Q4 2016 in Review

VHCP Management held its Sio Gene Therapies Inc. Common Stock (SIOX) position steady in Q4 2016 at 23,014 shares worth $2.29M. The position accounts for 2.46% of the portfolio, ranked #10.

VHCP Management first reported a position in SIOX in Q1 2016 and has held it in 4 quarters since. The position peaked at $2.58M in Q3 2016. 101 funds tracked by Wall St. Rank hold SIOX as of Q4 2016.

  • VHCP Management held 23,014 shares of Sio Gene Therapies Inc. Common Stock worth $2.29M as of Q4 2016.
  • VHCP Management left its Sio Gene Therapies Inc. Common Stock share count unchanged in Q4 2016.
  • Sio Gene Therapies Inc. Common Stock made up 2.46% of VHCP Management's portfolio in Q4 2016, its #10 holding.
  • VHCP Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q1 2016 and has held it in 4 quarters since.
  • VHCP Management's Sio Gene Therapies Inc. Common Stock position peaked at $2.58M in Q3 2016.
  • 101 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2016.

Based on VHCP Management's 13F filing for Q4 2016, filed 13 Feb 2017.